CXCL10 and type 2 diabetes mellitus: Specifically, the results were as follows: CXCL10‐hypothyroidism/myxoedema (β = 0.016, p = 0.045), hypothyroidism/myxoedema‐CXCL10 (β = 0.971, p = 0.0006), CXCL10‐T2D (β = 0.079, p = 0.036), T2D‐CXCL10 (β = −0.038, p = 0.017) and CXCL10‐hypoglycaemia (β = 0.307, p = 0.029) (Table S9 and Figure 4).